Here are 10 hospitals and health systems that posted job listings seeking pharmacy leadership talent in the last week.
Pharmacy
Hospitals mark up drugs three to seven times more than what Medicare charges for the same medication, a new study from Wall Street firm AllianceBernstein found.
The House Ways and Means Committee heard several testimonies on proposals to lower drug prices in the U.S., according to Regulatory Focus.
Imerys Talc America, which supplies talc for Johnson & Johnson's baby powder, filed for Chapter 11 bankruptcy Feb. 13, according to Bloomberg.
The World Health Organization is warning patients, physicians and pharmacies about a fake cancer drug that is circulating in the U.S. and Europe, according to The Guardian.
Mylan launched its generic version of GlaxoSmithKline's asthma treatment Advair at a price 70 percent lower than the branded treatment, according to Reuters.
After several years of declining revenues, top generic drug maker Teva Pharmaceuticals will turn to high-priced biotech medications in an effort to jumpstart growth, The Wall Street Journal reports.
A federal judge has ruled that AbbVie must turn over documents in a lawsuit that accuses the drugmaker of using "unclean hands" to create a thicket of patents to protect its best-selling drug Humira from competition, according to STAT.
Ahead of the 2020 presidential race, New Jersey Democrat Sen. Cory Booker is working to shed his reputation of being a friend of the pharmaceutical industry, STAT reports.
Johnson & Johnson will shell out $3.4 billion in cash to buy robotic surgery company Auris Health, CNBC reports.